Inogen (INGN) Cash from Investing Activities (2013 - 2026)
Inogen's (INGN) quarterly Cash from Investing Activities came in at -$2.0 million in Q1 2026, up 3.09% year-on-year from -$1.9 million in Q1 2025, and down 30.28% on a QoQ basis from -$1.5 million in Q4 2025.
Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Cash from Investing Activities data on file, last reported at -$2.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 3.09% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$26.1 million, a 917.75% decrease from a year earlier, with the FY2025 full-year figure at -$26.2 million, down 87.54% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$2.0 million, down from -$1.5 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for INGN reached as high as $11.5 million in Q4 2024 and fell as low as -$45.8 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$2.0 million in 2025.
- Across the five-year window, Cash from Investing Activities jumped 210.57% in 2022 and sank 2191.85% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$6.9 million in 2022, then jumped by 159.45% to $4.1 million in 2023, then jumped by 179.55% to $11.5 million in 2024, then tumbled by 113.14% to -$1.5 million in 2025, then sank by 30.28% to -$2.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn | -1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.98 Mn |
| Mar 31, 2026 | -1.98 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -22.57 Mn |
| Jun 30, 2025 | -22.57 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Sep 30, 2024 | 305,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | -12.38 Mn |
| Jun 30, 2024 | -12.38 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Dec 31, 2023 | 4.13 Mn |